Stay updated on Efficacy of Liraglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Liraglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the Efficacy of Liraglutide in Type 2 Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page displays the ClinicalTrials.gov record for the completed LIRALUNG study, which evaluated liraglutide’s effect on lung function in people with type 2 diabetes. It includes the study design, participant criteria, measured outcomes, locations, record dates, and related publications.SummaryDifference55%

- Check18 days agoChange DetectedThe footer site revision changes from v3.7.2 to v3.8.0; the page otherwise displays a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA sitewide notice announces an NIH transition update, including a change in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.0 to v3.7.1. The page otherwise remains a 403 Forbidden error screen.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page now renders a 403 Forbidden error page, replacing the expected study record content with a standard access-denied screen and site chrome.SummaryDifference19%

Stay in the know with updates to Efficacy of Liraglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Liraglutide in Type 2 Diabetes Clinical Trial page.